 | • レポートコード：MRC-IM30113 • 出版社/出版日：IMARC / 2022年10月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年311億ドルであった世界のバイオマーカー技術市場規模が2027年には677億ドルに達し、予測期間中、年平均13.71％成長すると予測しています。本調査レポートでは、バイオマーカー技術の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、検査種類別（ソリッドバイオプシー、リキッドバイオプシー）分析、疾患別（がん、感染症、自己免疫疾患、心血管疾患、その他）分析、製品別（消耗品、アッセイ、試薬、器具）分析、技術別（ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、イムノアッセイ、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., LI-COR Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のバイオマーカー技術市場規模：検査種類別 - ソリッドバイオプシーにおける市場規模 - リキッドバイオプシーにおける市場規模 ・世界のバイオマーカー技術市場規模：疾患別 - がんにおける市場規模 - 感染症における市場規模 - 自己免疫疾患における市場規模 - 心血管疾患における市場規模 - その他疾患における市場規模 ・世界のバイオマーカー技術市場規模：製品別 - バイオマーカー技術消耗品の市場規模 - バイオマーカー技術アッセイの市場規模 - バイオマーカー技術試薬の市場規模 - バイオマーカー技術器具の市場規模 ・世界のバイオマーカー技術市場規模：技術別 - ポリメラーゼ連鎖反応（PCR）における市場規模 - 次世代シーケンシング（NGS）における市場規模 - イムノアッセイにおける市場規模 - その他技術における市場規模 ・世界のバイオマーカー技術市場規模：地域別 - 北米のバイオマーカー技術市場規模 - アジアのバイオマーカー技術市場規模 - 欧州のバイオマーカー技術市場規模 - 中南米のバイオマーカー技術市場規模 - 中東・アフリカのバイオマーカー技術市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global biomarker technologies market size reached US$ 31.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 67.7 Billion by 2027, exhibiting a growth rate (CAGR) of 13.71% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Biomarker technologies are reliable and cost-effective detection tools that rely on genetic biomarkers, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), for detecting pathogens. These technologies find extensive application in the early diagnosis of different diseases and disorders. They are also utilized in the drug discovery and development processes and the management of nervous system disorders, cardiovascular diseases, infections, immunological and genetic disorders, and cancer. Some of the commonly used biomarker technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS) and immunoassay.
Biomarker Technologies Market Trends:
There is currently a considerable rise in the number of individuals who are suffering from cancer and cardiovascular, neurological, and autoimmune diseases across the globe. This, coupled with the escalating demand for early and effective diagnosis, represents one of the key factors positively influencing the market. Apart from this, the rising geriatric population is also contributing to the growth of the market. Moreover, there is an increase in research and development (R&D) funding for drug discovery by governing agencies of numerous countries. This, along with the considerably expanding healthcare infrastructure, especially in developing countries, is propelling the market growth. Furthermore, leading market players are introducing numerous advancements in biomarker technologies that provide accurate patient stratification. They are also developing digital biomarkers that aid in collecting objective, quantifiable, physiological, and behavioral data by using digital devices. These digital biomarkers are also incorporated with artificial intelligence (AI), machine learning (ML) solutions for big data analysis, and integrated decision making. Other major factors, including rising awareness about the early detection of cancer for better treatment, and surging income levels of individuals, are projected to impel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biomarker technologies market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on test type, indication, product, technology and application.
Breakup by Test Type:
Solid Biopsy
Liquid Biopsy
Breakup by Indication:
Cancer
Infectious Diseases
Autoimmune Disorders
Cardiovascular Disorders
Others
Breakup by Product:
Consumables
Assay
Reagent
Instruments
Breakup by Technology:
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Immunoassay
Others
Breakup by Application:
Drug Discovery
Clinical Diagnostics
Personalized Medicine
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., LI-COR Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation.
Key Questions Answered in This Report:
How has the global biomarker technologies market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global biomarker technologies market?
What are the key regional markets?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global biomarker technologies market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biomarker Technologies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Test Type
6.1 Solid Biopsy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Liquid Biopsy
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Indication
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Infectious Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Autoimmune Disorders
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular Disorders
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Product
8.1 Consumables
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Assay
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Reagent
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Instruments
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Technology
9.1 Polymerase Chain Reaction (PCR)
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Next Generation Sequencing (NGS)
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Immunoassay
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Application
10.1 Drug Discovery
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinical Diagnostics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Personalized Medicine
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Agilent Technologies Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Bio-Rad Laboratories Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Danaher Corporation
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 F. Hoffmann-La Roche AG
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Illumina Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 LI-COR Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Merck KGaA
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 PerkinElmer Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 QIAGEN N.V.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Shimadzu Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Thermo Fisher Scientific Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Waters Corporation
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
Figure 2: Global: Biomarker Technologies Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Biomarker Technologies Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Biomarker Technologies Market: Breakup by Test Type (in %), 2021
Figure 5: Global: Biomarker Technologies Market: Breakup by Indication (in %), 2021
Figure 6: Global: Biomarker Technologies Market: Breakup by Product (in %), 2021
Figure 7: Global: Biomarker Technologies Market: Breakup by Technology (in %), 2021
Figure 8: Global: Biomarker Technologies Market: Breakup by Application (in %), 2021
Figure 9: Global: Biomarker Technologies Market: Breakup by Region (in %), 2021
Figure 10: Global: Biomarker Technologies (Solid Biopsy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Biomarker Technologies (Solid Biopsy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Biomarker Technologies (Liquid Biopsy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Biomarker Technologies (Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Biomarker Technologies (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Biomarker Technologies (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Biomarker Technologies (Infectious Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Biomarker Technologies (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Biomarker Technologies (Autoimmune Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Biomarker Technologies (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Biomarker Technologies (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Biomarker Technologies (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Biomarker Technologies (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Biomarker Technologies (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Biomarker Technologies (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Biomarker Technologies (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Biomarker Technologies (Assay) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Biomarker Technologies (Assay) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Biomarker Technologies (Reagent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Biomarker Technologies (Reagent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Biomarker Technologies (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Biomarker Technologies (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Biomarker Technologies (Immunoassay) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Biomarker Technologies (Immunoassay) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Biomarker Technologies (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Biomarker Technologies (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Biomarker Technologies (Drug Discovery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Biomarker Technologies (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Biomarker Technologies (Clinical Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Biomarker Technologies (Clinical Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Biomarker Technologies (Personalized Medicine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Biomarker Technologies (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: North America: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: North America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: United States: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: United States: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Canada: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Canada: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Asia-Pacific: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Asia-Pacific: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: China: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: China: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Japan: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Japan: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: India: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: India: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: South Korea: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: South Korea: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Australia: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Australia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Indonesia: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Indonesia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Europe: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Europe: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Germany: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Germany: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: France: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: France: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: United Kingdom: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: United Kingdom: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Italy: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Italy: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Spain: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Spain: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Russia: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Russia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Latin America: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Latin America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Brazil: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Brazil: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Mexico: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Mexico: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Middle East and Africa: Biomarker Technologies Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Middle East and Africa: Biomarker Technologies Market: Breakup by Country (in %), 2021
Figure 94: Middle East and Africa: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Global: Biomarker Technologies Industry: SWOT Analysis
Figure 96: Global: Biomarker Technologies Industry: Value Chain Analysis
Figure 97: Global: Biomarker Technologies Industry: Porter's Five Forces Analysis
• 日本語訳：バイオマーカー技術の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30113 ▷ お問い合わせ（見積依頼・ご注文・質問）